RESCUE MEDICATION USE REDUCTION WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA

被引：1
|
作者：
O'Quinn, S.
Xu, X.
Hirsch, I.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.057
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D200
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Comprehensive Response to Benralizumab by Patients with Nasal Polyposis and Severe, Eosinophilic Asthma
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Gil, Garcia E. G.
    PNEUMOLOGIE, 2021, 75 : S34 - S35
  • [32] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [33] Improved small airway function by benralizumab in patients with severe eosinophilic asthma
    Badal, Tanya
    Reed, Nicola
    Seccombe, Leigh M.
    Cottee, Alice M.
    Thamrin, Cindy
    King, Gregory G.
    Peters, Matthew J.
    Farah, Claude S.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
    Davison, John
    Doe, Simon
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [35] WINNING THE BATTLE OVER UNCONTROLLED ASTHMA AND CHRONIC EOSINOPHILIC PNEUMONIA WITH BENRALIZUMAB
    Ngassa, Marina
    Murugesan, Neveda
    Narendra, Dharani Kumari
    CHEST, 2024, 166 (04) : 4927A - 4928A
  • [36] Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials
    Trudo, F.
    Hirsch, I.
    Gopalan, G.
    Martin, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma
    Albers, Frank C.
    Bratton, Daniel J.
    Gunsoy, Necdet B.
    Cockle, Sarah M.
    Alfonso-Cristancho, Rafael
    Braunstahl, Gert-Jan
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (03): : 252 - 258
  • [38] Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
    Gomez-Bastero Fernandez, Ana
    Medina Gallardo, Juan Francisco
    Delgado Romero, Julio
    Romero Falcon, Auxiliadora
    Benito Bernaldez, Cristina
    Gallego Borrego, Javier
    Javier Alvarez-Gutierrez, Francisco
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 727 - 735
  • [39] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [40] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
12345